Date | Time | Source | Headline | Symbol | Company |
02/08/2024 | 7:22PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/19/2023 | 4:48PM | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/12/2023 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 10:17AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 10:12AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 10:05AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 10:02AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 9:27AM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 9:27AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 9:24AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 9:22AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 9:22AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 9:22AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 9:22AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 9:21AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 9:20AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 9:19AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 9:19AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 8:56AM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 8:31AM | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 8:17AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/11/2023 | 8:00AM | PR Newswire (US) | HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINE | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/04/2023 | 5:29PM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
10/04/2023 | 4:05PM | GlobeNewswire Inc. | Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
09/29/2023 | 9:00AM | GlobeNewswire Inc. | Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023 | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
09/27/2023 | 8:25AM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
09/27/2023 | 8:12AM | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
09/27/2023 | 8:00AM | PR Newswire (US) | HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC. | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
09/15/2023 | 8:00AM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
09/14/2023 | 4:59PM | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |